Publication Search Directions

The search fields below can be used to filter articles by Title, Author, Keyword, or Publication Name. 

To see all available articles, ensure all search fields are cleared and click "Apply"

Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Vilox

Authors
A. Nasser
A. Kosheleff
J. Hull
T. Liranso
P Qin
G. Busse
W. O'Neal
M. Fava
S. Faraone
J. Rubin
Keywords
ADHD
ADHD Children and Adolescents
SPN-812
Extended-release viloxazine
812
Journal
Journal Of Child And Adolescent Psychopharmacology
Year Published
2021

Functional Impairments Associated with ADHD: A Post Hoc Analysis of Data From Pediatric Clinical Trials of Viloxazine Extended-Release Capsules*

Authors
Azmi Nasser
Joseph Hull
Tesfaye Liranso
Gregory Busse
Zare Melyan
Ann Childress
Frank Lopez
Jonathan Rubin
Keywords
extended-release viloxazine capsules
Extended-release viloxazine
ADHD Children and Adolescents
Pediatric ADHD
Qelbree
Journal
World Congress 2021
Year Published
2021

A Pooled Analysis of Four Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies Assessing Efficacy of SPN-812 (Viloxazine Extended Release) in Children and Adolescents With ADHD

Authors
A Nasser
J Hull
F Chowdhry
T Adewole
T Liranso
G Busse
S Schwabe
Keywords
Extended-release viloxazine
ADHD Children and Adolescents
SPN-812
Journal
American Professional Society of ADHD and Related Disorders 2020 Annual Meeting
Year Published
2020

A Pooled Analysis of Four Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies Assessing Efficacy of SPN-812 (Viloxazine Extended Release) in Children and Adolescents With ADHD

Authors
A. Nasser
J. Hull
F. Chowdhry
T Adewole
T. Liranso
G. Busse
S. Schwabe
Keywords
SPN-812
Extended-release viloxazine
ADHD Children and Adolescents
Poster
Journal
Nevada Psychiatric Association 2020 Annual Meeting February 12-15, 2020, Las Vegas, NV
Year Published
2020

A Phase III, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Once-Daily SPN-812 (Viloxazine Extended-Release) in the Treatment of Attention-Deficit/Hyperactivity Disorder in School-age Children

Authors
A. Nasser
T Liranso
T. Adewole
N. Fry
J. Hull
F. Chowdhry
G. Busse
A. Cutler
N. Joshi Jones
R. Findling
S. Schwabe
Keywords
ADHD
ADHD-RS-5
Viloxazine
SPN-812
Conners 3
WFIRS
ADHD Hyperactivity Disorder in Children
Journal
Clinical Therapeutics
Year Published
2020

Evaluation of the Effect of SPN-812 (Viloxazine Extended Release) on the Relative Bioavailability of Lisdexamfetamine Dimesylate and Methylphenidate in Healthy Adults

Authors
F. Faison
N. Fry
T Adewole
O Odebo
J Xu
G Busse
S Schwabe
A Nasser
Keywords
Extended-release viloxazine
Viloxazine
Lisdexamfetamine Dimesylate
methylphenidate
SPN-812
Journal
American Professional Society of ADHD and Related Disorders 2020 Annual Meeting
Year Published
2020

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P302) Assessing the Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) 200 and 400 mg for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Adolescents

Authors
A Nasser
J Hull
F Chowdhry
T Adewole
T Liranso
S Schwabe
Keywords
SPN-812
Extended-release viloxazine
ADHD Hyperactivity Disorder in Adolescents
ADHD
NEI 2019
Journal
Neuroscience Education Institute 15th Annual Congress; Nov. 7-10, 2019
Year Published
2019

Extended-Release Viloxazine (SPN-812) 100 mg or 200 mg for the Treatment of ADHD in Children: Topline Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P301)

Authors
A Nasser
J Hull
F Chowdhry
T Adewole
T Liranso
S Schwabe
Keywords
Extended-release viloxazine
ADHD Hyperactivity Disorder in Children
SPN-812
SDBP 2019
Journal
SDBP Society for Developmental and Behavioral Pediatrics Annual Meeting, September 13-16, 2019
Year Published
2019

Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Extended-Release Viloxazine (SPN-812) for Pediatric ADHD: Update on the Second Adolescent Study (P304)

Authors
A Nasser
J Hull
F Chowdhry
T Adewole
T Liranso
R Marcus
Keywords
Viloxazine
SPN-812
Poster
ADHD
Extended-release viloxazine
Non-stimulant
Journal
Presented at the Nevada Psychiatric Association 24th National Psychopharmacology
Year Published
2019

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P303) Assessing the Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) 200 and 400 mg for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children

Authors
A Nasser
J Hull
F Chowdhry
T Adewole
T Liranso
S Schwabe
Keywords
Extended-release viloxazine
P303
SPN-812
ADHD Children
Journal
Neuroscience Education Institute 15th Annual Congress; Nov. 7-10, 2019
Year Published
2019

Evaluation of the Effect of SPN-812 (Extended-Release Viloxazine) on the Pharmacokinetics of Concerta® in Healthy Adults

Authors
Shamia L. Faison, PhD
Nicholas Fry
Toyin Adewole, MD, MPH
Oyinkansola Odebo, MD, MPH
Jiahong Xu, MS, MPH
Azmi Nasser, PhD
Keywords
SPN-812
Extended-release viloxazine
Pharmacokinetic Concerta
Poster
Journal
Presented at the ASCP 2019 Annual Meeting; May 28–31, 2019; Scottsdale, AZ
Year Published
2019

Evaluation of the Effect of SPN-812 (Extended-Release Viloxazine) on the Pharmacokinetics of Vyvanse® in Healthy Adults

Authors
Shamia L. Faison, PhD
Nicholas Fry
Toyin Adewole, MD, MPH
Oyinkansola Odebo, MD, MPH
Jiahong Xu, MS, MPH
Azmi Nasser, PhD
Keywords
SPN-812
Extended-release viloxazine
Pharmacokinetics of Vyvanse
Poster
Journal
Presented at the ASCP 2019 Annual Meeting; May 28–31, 2019; Scottsdale, AZ
Year Published
2019

Developing and Validating a Definition of Impulsive/Reactive Agression in Youth

Authors
Andrea S. Young
Eric A. Youngstrom
Robert L. Findling
Kathryn Van Eck
Dana Kaplin
Jennifer K. Youngstrom
Joseph Calabrese
Ekaterina Stepanova & The LAMS Consortium
Keywords
Impulsive aggression
Impulsive aggression
SPN-810
810
IA
Molindone
Extended Release Molindone
Journal
Journal of Clinical Child and Adolescent Psychology
Volume
Volume 48, 2019
Year Published
2019

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P301) Assessing the Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) 100 and 200 mg for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children

Authors
Azmi Nasser, PhD
Joseph T. Hull, PhD
Fatima A. Chowdhry, MD
Toyin Adewole, MD, MPH
Tesfaye Liranso, PhD
Stefan Schwabe, MD, PhD
Keywords
SPN-812
Extended-release viloxazine
ADHD
attention deficit/hyperactivity disorder
AACAP 2019
Poster
Journal
AACAP Annual Meeting, October 2019
Year Published
2019

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P302) Assessing the Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) 200 and 400 mg for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Adolescents

Authors
A Nasser
J Hull
F Chowdhry
T Adewole
T Liranso
S Schwabe
Keywords
Extended-release viloxazine
SPN-812
ADHD
attention deficit/hyperactivity disorder
AACAP 2019
Journal
AACAP 2019 Annual Meeting
Year Published
2019

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P303) Assessing the Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) 200 and 400 mg for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children

Authors
A Nasser
J Hull
F Chowdhry
T Adewole
T Liranso
S Schwabe
Keywords
SPN-812
Extended-release viloxazine
ADHD
attention deficit/hyperactivity disorder
Poster
Journal
AACAP 2019 Annual Meeting
Year Published
2019

Structural Elucidation of the Major Human Metabolites of Viloxazine

Authors
E. Barton
R. Cooke
D. Williams
C. Yu
Keywords
Viloxazine
Extended-release viloxazine
ADHD
SPN-812
Poster
Journal
12th International ISSX Meeting, July 27-31, 2019, Portland, OR
Year Published
2019

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P301) Assessing the Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) 100 and 200 mg for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children

Authors
A. Nasser
J. Hull
F. Chowdhry
T. Adewole
T. Liranso
S. Schwabe
Keywords
Extended-release viloxazine
ADHD
attention deficit/hyperactivity disorder
ADHD Hyperactivity Disorder in Children
Journal
Neuroscience Education Institute 15th Annual Congress; Nov. 7-10, 2019
Year Published
2019

Reproductive toxicology studies supporting the safety of molindone, a dopamine receptor antagonist.

Authors
G. Gopalakrishnan
S. Ganiger
TEK White
C. Yu
Keywords
development
rabbit
rat
embryo
fertility
fetus
Molindone
Molindone HCl
postnatal
Reproduction
SPN-810
Impulsive aggression
Maladaptive Aggression
Impulsive Aggression Modulators
Extended Release Molindone
ADHD
Anti-Maladaptive Aggression Agents
Starting Page
1250
Journal
Birth Defects Res.
Volume
110
Year Published
2018
VNumber
16

Reversibility of dopamine receptor antagonist-inducedhyperprolactinemia and associated histological changes in Tg RasH2wild-type mice

Authors
Gopala Krishna
Shivaputhrappa Ganiger
Kamala Kannan
Gopa Gopalakrishnan
Saryu Goel
Keywords
Molindone
Impulsive aggression
ADHD
Prolactin
Reproduction
Endocrine
SPN-810
Maladaptive Aggression
Impulsive Aggression Modulators
Extended Release Molindone
Anti-Maladaptive Aggression Agents
Starting Page
73
Journal
Reproductive Toxicology
Volume
58
Year Published
2015
VNumber
58

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial

Authors
J.A. French
P. Baroldi
S.T. Brittain
J.K. Johnson
Keywords
Extended-Release
Oxcarbazepine
Partial-onset seizures
Adjunctive therapy
Refractory epilepsy
Starting Page
143
Journal
Acta Neruologica Scandinavica
Volume
129
Year Published
2014
VNumber
129

A Phase 2a Randomized, Parallel Group, Dose-Ranging Study of Molindone in Children with Attention-Deficit/Hyperactivity Disorder and Persistent, Serious Conduct Problems

Authors
Jennifer D. Stocks, M. Sc., et. al.
Keywords
Molindone
ADHD
Phase 2a
SPN-810
Impulsive aggression
Maladaptive Aggression
Impulsive Aggression Modulators
Anti-Maladaptive Aggression Agents
Extended Release Molindone
Journal
Journal Of Child And Adolescent Psychopharmacology
Volume
22
Year Published
2012
VNumber
2